Identification of Potential Biomarkers of Papillary Thyroid Carcinoma

Overview

Journal Endocrine

Specialty Endocrinology

Date 2024 Oct 14

PMID 39400774

Authors

Sabire Kilicarslan

Meliha Merve Hiz-Cicekliyurt

Affiliations

Soon will be listed here.

Abstract

Aim: This study aimed to identify candidate biomarkers for papillary thyroid carcinoma using an integrative analysis of bioinformatics and machine learning (ML).

Material And Method: The PTC datasets GSE6004, GSE3467, and GSE33630 (species: Homo sapiens) were downloaded from NCBI and analyzed using the limma package to obtain DEGs. Once DEGs were identified, GO and KEGG enrichment analyses were performed as the first step in the bioinformatics process. Subsequently, a protein-protein interaction (PPI) network was constructed according to the common genes in bioinformatics and machine learning using STRING to elucidate the important genes involved in PTC pathogenesis. In machine learning, finding genes entails feature selection to identify the key genes that distinguish biological states. Hybrid feature selection will be used for this. In the second step, the original data sets were preprocessed to detect and correct missing and noisy data; after that, all data were merged. Following performing Linear and Discriminative Hybrid Feature Selection (LDHFS) on the processed dataset, machine learning algorithms such as Random Forest (RF), Naive Bayes (NB), and Support Vector Machines (SVM) are utilized.

Results: Bioinformatics and machine learning analyses indicate that the genes RXRG, CDH2, ETV5, QPCT, LRP4, FN1, and LPAR5 are integral to the progression of thyroid cancer. This study attained the highest accuracy utilizing the RF algorithm, achieving an accuracy rate of 94.62%, a Kappa value of 91.36%, and an AUC value of 96.13%. These results offer additional evidence and confirmation for the genetic alterations of these genes. These findings may accelerate the development of prospective therapeutic and diagnostic methods in future research.

Conclusions: Bioinformatics and machine learning techniques identified the common genes "RXRG, CDH2, ETV5, QPCT, LRP4, FN1, and LPAR5" as PTC biomarkers, providing novel reference markers for the diagnosis and treatment of PTC patients. The model is anticipated to possess significant predictive value and assist in the early diagnosis and screening of clinical PTC. These insights enhance the field of PTC management and offer guidance for future research.

References

Siegel R, Giaquinto A, Jemal A . Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49. DOI: 10.3322/caac.21820. View

Deng Y, Li H, Wang M, Li N, Tian T, Wu Y . Global Burden of Thyroid Cancer From 1990 to 2017. JAMA Netw Open. 2020; 3(6):e208759. PMC: 7320301. DOI: 10.1001/jamanetworkopen.2020.8759. View

Gharib H, Papini E, Valcavi R, Baskin H, Crescenzi A, Dottorini M . American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2006; 12(1):63-102. DOI: 10.4158/EP.12.1.63. View

Fugazzola L, Muzza M, Pogliaghi G, Vitale M . Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance. Cancers (Basel). 2020; 12(2). PMC: 7072350. DOI: 10.3390/cancers12020383. View

Liao M, Wang Z, Yao J, Xing H, Hao Y, Qiu B . Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis. Mol Cell Biochem. 2023; 478(9):2111-2123. DOI: 10.1007/s11010-022-04606-x. View

Petrini I, Cecchini R, Mascaro M, Ponzoni I, Carballido J . Papillary Thyroid Carcinoma: A thorough Bioinformatic Analysis of Gene Expression and Clinical Data. Genes (Basel). 2023; 14(6). PMC: 10298340. DOI: 10.3390/genes14061250. View

Ren H, Liu X, Li F, He X, Zhao N . Identification of a Six Gene Prognosis Signature for Papillary Thyroid Cancer Using Multi-Omics Methods and Bioinformatics Analysis. Front Oncol. 2021; 11:624421. PMC: 8012734. DOI: 10.3389/fonc.2021.624421. View

Shang J, Ding Q, Yuan S, Liu J, Li F, Zhang H . Network Analyses of Integrated Differentially Expressed Genes in Papillary Thyroid Carcinoma to Identify Characteristic Genes. Genes (Basel). 2019; 10(1). PMC: 6356810. DOI: 10.3390/genes10010045. View

Vasko V, Espinosa A, Scouten W, He H, Auer H, Liyanarachchi S . Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A. 2007; 104(8):2803-8. PMC: 1815262. DOI: 10.1073/pnas.0610733104. View

10.

He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S . The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005; 102(52):19075-80. PMC: 1323209. DOI: 10.1073/pnas.0509603102. View

11.

Tomas G, Tarabichi M, Gacquer D, Hebrant A, Dom G, Dumont J . A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic. Oncogene. 2012; 31(41):4490-8. DOI: 10.1038/onc.2011.626. View

12.

Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I . Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001; 125(1-2):279-84. DOI: 10.1016/s0166-4328(01)00297-2. View

13.

Bei Y, Hong P . A novel approach to minimize false discovery rate in genome-wide data analysis. BMC Syst Biol. 2014; 7 Suppl 4:S1. PMC: 3856609. DOI: 10.1186/1752-0509-7-S4-S1. View

14.

Reiner A, Yekutieli D, Benjamini Y . Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 2003; 19(3):368-75. DOI: 10.1093/bioinformatics/btf877. View

15.

Stevens R, Goble C, Bechhofer S . Ontology-based knowledge representation for bioinformatics. Brief Bioinform. 2001; 1(4):398-414. DOI: 10.1093/bib/1.4.398. View

16.

Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M . KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2007; 36(Database issue):D480-4. PMC: 2238879. DOI: 10.1093/nar/gkm882. View

17.

Braun P, Gingras A . History of protein-protein interactions: from egg-white to complex networks. Proteomics. 2012; 12(10):1478-98. DOI: 10.1002/pmic.201100563. View

18.

Urbanowicz R, Meeker M, La Cava W, Olson R, Moore J . Relief-based feature selection: Introduction and review. J Biomed Inform. 2018; 85:189-203. PMC: 6299836. DOI: 10.1016/j.jbi.2018.07.014. View

19.

Meng D, Li Z, Ma X, Wu L, Fu L, Qin G . ETV5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA. Life Sci. 2020; 253:117693. DOI: 10.1016/j.lfs.2020.117693. View

20.

Gaikwad S, Gunjal L, Junutula A, Astanehe A, Gambhir S, Ray P . Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models. PLoS One. 2013; 8(2):e55971. PMC: 3564913. DOI: 10.1371/journal.pone.0055971. View